INVESTIGATION OF IL-6 EFFECTS ON SP-A EXPRESSION IN A549 LUNG CELL LINE

被引:7
|
作者
Doumanov, J. [1 ]
Jordanova, A. [2 ]
Zlatkov, K. [1 ]
Moskova-Doumanova, V. [3 ]
Lalchev, Z. [1 ]
机构
[1] SU St Kl Ohridski, Fac Biol, Dept Biochem, Sofia, Bulgaria
[2] Bulgarian Acad Sci, Dept Lipid Prot Interact, Inst Biophys & Biomed Engn, Sofia, Bulgaria
[3] SU St Kl Ohridski, Fac Biol, Dept Cytol Histol & Embryol, Sofia, Bulgaria
关键词
interleukin-6; surfactant protein A; A549; cells;
D O I
10.5504/50YRTIMB.2011.0018
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Interleukin-6 (IL-6) is a multifunctional cytokine that is important in inflammatory processes, cell differentiation and growth. Pulmonary surfactant is a protein-lipid complex, which reduce surface tension at the alveolar air-liquid interface, thereby preventing lung collapse. Surfactant protein A (SP-A) is the most abundant of four surfactant proteins (SP-A, SP-B, SP-C and SP-D). It binds to alveolar macrophages, stimulates their chemotaxis and serves as an opsonin in the phagocytosis. Low SP-A levels are associated with increased inflammation in the lung. In the absence of infection SP-A inhibited IL-6 production. In infected macrophages, SP-A augmented IL-6 production. In humans, SP-A levels are altered by a number of disease states. In some of them there is increased levels of SP-A in the bronchoalveolar lavage fluid. Here we investigate presence/absence of correlation between increased levels of IL-6 and production of SP-A from A549 lung cell line. Our results suggest that incubation of A549 cells with IL-6 for different time changes significantly the expression levels of SP-A.
引用
收藏
页码:96 / 99
页数:4
相关论文
共 50 条
  • [1] Monophthalates promote IL-6 and IL-8 production in the human epithelial cell line A549
    Jepsen, KF
    Abildtrup, A
    Larsen, ST
    TOXICOLOGY IN VITRO, 2004, 18 (03) : 265 - 269
  • [2] Sp1 Upregulates Survivin Expression in Adenocarcinoma of Lung Cell Line A549
    Chen, Yuqing
    Wang, Xiaojing
    Li, Wei
    Zhang, Hailong
    Zhao, Chengling
    Li, Yan
    Wang, Zhenhuan
    Chen, Changjie
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2011, 294 (05): : 774 - 780
  • [3] Effects of Lung Carcinogens on PPARgamma Activity in A549 Cell Line
    Carrasco, Nestor
    Tennis, Meredith
    Nield, Lori
    FASEB JOURNAL, 2015, 29
  • [4] Gene expression alterations in hypoxic A549 lung cancer cell line
    Abualnadi, Rania
    Tarboush, Nafez Abu
    Shhab, Mohammad
    Zihlif, Malek
    BIOMEDICAL REPORTS, 2024, 21 (06)
  • [5] In vitro effects of pyrrolizidine alkaloids in the lung adenocarcinoma cell line A549
    Buchmuller, J.
    Pellowski, D.
    Braeuning, A.
    Hessel-Pras, S.
    TOXICOLOGY LETTERS, 2021, 350 : S96 - S96
  • [6] Antiproliferative and Antimigratory Effects of Enoxaparin on the Lung Adenocarcinoma A549 Cell Line
    Alturkistani, Azhaar
    Power-Charnitsky, Verna-Ann
    Ghonem, Nisanne
    Migliore, Mattia M.
    FASEB JOURNAL, 2017, 31
  • [7] Investigation of New Benzimidazole Derivative Compounds' Effects on A549 Cell Line
    Duran, Gulay Gulbol
    Kucuk, Meral Urhan
    Algul, Oztekin
    Terzi, Menderes Yusuf
    BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, 2020, 63
  • [8] Hepatocyte growth factor, IL-6, and cell matrix interactions in A549 adenocarcinoma growth
    Awanis, Griselda
    Raveenthiraraj, Sathuwarman
    Sobolewski, Anastasia
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2603 - 2603
  • [9] Diosgenin Inhibits hTERT Gene Expression in the A549 Lung Cancer Cell Line
    Mohammad, Rahmati Yamchi
    Somayyeh, Ghareghomi
    Gholamreza, Haddadchi
    Majid, Mobasseri
    Yousef, Rasmi
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (11) : 6945 - 6948
  • [10] Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549
    Silva, Izabella Thais
    Geller, Fabiana Cristina
    Persich, Lara
    Dudek, Sabine Eva
    Lang, Karen Luise
    Balparda Caro, Miguel Soriano
    Duran, Fernando Javier
    Schenkel, Eloir Paulo
    Ludwig, Stephan
    Oliveira Simoes, Claudia Maria
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (02) : 139 - 148